Cognitive therapy software for improving cognitive function for patients with mild cognitive impairment (SB‐DEX): A multicenter, prospective, comparative, randomized, independent rater‐blind, superiority, pivotal clinical trial to compare the safety and efficacy of the Cognitive therapy software ‘SUPERBRAIN DEX’ for improving cognitive function with a control group for patients with mild cognitive impairment (ClinicalTrials.gov ID NCT06264557)

Furkejuvvon:

Bibliográfalaš dieđut
Publikašuvnnas:	Alzheimer's & Dementia vol. 21 (Dec 1, 2025)
Váldodahkki:	Choi, Hojin
Eará dahkkit:	Minn, Yangki, Kang, Sungmin, Han, Seunghyun
Almmustuhtton:	John Wiley & Sons, Inc.
Fáttát:	Cognitive functioning Intervention Cultural differences Function Safety Dementia Clinical trials Software Cognition Cognitive therapy Efficacy Cognitive ability Cognitive impairment Older people Standardization Artificial intelligence Clinical medicine Psychotherapy Research centers Treatment programs Patients Multiculturalism & pluralism Korean language Training Control groups Effectiveness Clinical research Mini-Mental State Examination Education Rules Intelligence tests Cognitive skills training Rehabilitation Will Medical treatment Therapy Computerization Dominance Physical disabilities
Liŋkkat:	Citation/Abstract Full Text - PDF
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!

Lasit vuosttaš kommeantta. Visot kommeanttat leat almmolaččat.!